Marshall H. Woodworth
Directeur Financier/CFO chez NEUROBO PHARMACEUTICALS, INC.
Fortune : 102 498 $ au 30/04/2024
Profil
Marshall H.
Woodworth currently works at NeuroBo Pharmaceuticals, Inc., as Chief Financial & Accounting Officer from 2023.
Mr. Woodworth also formerly worked at ANDRITZ Fabrics & Rolls, Inc., as Vice President-Finance in 2009, Aerocrine AB, as Chief Financial Officer in 2015, Furiex Pharmaceuticals, Inc., as CFO, Treasurer & Assistant Secretary from 2011 to 2013, Braeburn Pharmaceuticals SPRL, as Chief Financial Officer from 2015 to 2016, and Nevakar, Inc., as Chief Financial Officer from 2017 to 2023.
Mr. Woodworth received his Masters Business Admin degree from Indiana University and undergraduate degree from the University of Maryland.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/03/2024 | 33 496 ( 0,68% ) | 102 498 $ | 30/04/2024 |
Postes actifs de Marshall H. Woodworth
Sociétés | Poste | Début |
---|---|---|
NEUROBO PHARMACEUTICALS, INC. | Directeur Financier/CFO | 27/10/2023 |
Anciens postes connus de Marshall H. Woodworth
Sociétés | Poste | Fin |
---|---|---|
Nevakar, Inc.
Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ. | Directeur Financier/CFO | 01/05/2023 |
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Directeur Financier/CFO | 01/10/2016 |
AEROCRINE AB | Directeur Financier/CFO | 20/04/2015 |
FURIEX PHARMACEUTICALS INC | Directeur Financier/CFO | 14/11/2013 |
XERIUM TECHNOLOGIES, INC. | Directeur Financier/CFO | 01/01/2009 |
Formation de Marshall H. Woodworth
Indiana University | Masters Business Admin |
University of Maryland | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
NEUROBO PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
ANDRITZ Fabrics & Rolls, Inc.
ANDRITZ Fabrics & Rolls, Inc. TextilesProcess Industries ANDRITZ Fabrics & Rolls, Inc. manufactures and supplies consumable products. It offers pulp, paper, tissue, fiber, stock processing, nonwoven fabrics, industrial rolls, and building and specialty products. The company was founded in 1976 and is headquartered in Youngsville, NC. | Process Industries |
Aerocrine AB
Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
Furiex Pharmaceuticals, Inc.
Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
Braeburn Pharmaceuticals SPRL
Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Health Technology |
Nevakar, Inc.
Nevakar, Inc. Pharmaceuticals: MajorHealth Technology Nevakar, Inc. is a specialty injectable pharmaceutical company focused on developing innovative products in injectable and ophthalmic space. The company was founded by Navneet Puri in 2015 and is headquartered in Bridgewater, NJ. | Health Technology |